N-acetylcysteine as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia: a randomized, double-blind, placebo-controlled study M Farokhnia, A Azarkolah, F Adinehfar, MR Khodaie-Ardakani, ... Clinical neuropharmacology 36 (6), 185-192, 2013 | 175 | 2013 |
Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double‐blind randomized clinical … M Farokhnia, M Shafiee Sabet, N Iranpour, A Gougol, H Yekehtaz, ... Human Psychopharmacology: Clinical and Experimental 29 (4), 351-359, 2014 | 170 | 2014 |
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous … N Shahmansouri, M Farokhnia, SH Abbasi, SE Kassaian, AAN Tafti, ... Journal of Affective disorders 155, 216-222, 2014 | 165 | 2014 |
Cardiovascular considerations in antidepressant therapy: an evidence-based review H Yekehtaz, M Farokhnia, S Akhondzadeh The Journal of Tehran University Heart Center 8 (4), 169, 2013 | 132 | 2013 |
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: randomized double-blind placebo-controlled study MR Khodaie-Ardakani, O Mirshafiee, M Farokhnia, M Tajdini, ... Psychiatry research 215 (3), 540-546, 2014 | 110 | 2014 |
Galantamine efficacy and tolerability as an augmentative therapy in autistic children: A randomized, double-blind, placebo-controlled trial A Ghaleiha, M Ghyasvand, MR Mohammadi, M Farokhnia, N Yadegari, ... Journal of Psychopharmacology 28 (7), 677-685, 2014 | 81 | 2014 |
Simvastatin as an adjuvant therapy to fluoxetine in patients with moderate to severe major depression: A double-blind placebo-controlled trial A Gougol, N Zareh-Mohammadi, S Raheb, M Farokhnia, S Salimi, ... Journal of Psychopharmacology 29 (5), 575-581, 2015 | 73 | 2015 |
Double-blind, placebo-controlled trial of risperidone plus amantadine in children with autism: a 10-week randomized study MR Mohammadi, N Yadegari, E Hassanzadeh, M Farokhnia, H Yekehtaz, ... Clinical Neuropharmacology 36 (6), 179-184, 2013 | 59 | 2013 |
Riluzole as an adjunctive therapy to risperidone for the treatment of irritability in children with autistic disorder: a double-blind, placebo-controlled, randomized trial A Ghaleiha, E Mohammadi, MR Mohammadi, M Farokhnia, ... Pediatric Drugs 15, 505-514, 2013 | 57 | 2013 |
The effects of pioglitazone adjuvant therapy on negative symptoms of patients with chronic schizophrenia: a double‐blind and placebo‐controlled trial N Iranpour, A Zandifar, M Farokhnia, A Goguol, H Yekehtaz, ... Human Psychopharmacology: Clinical and Experimental 31 (2), 103-112, 2016 | 46 | 2016 |
A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia M Farokhnia, M Sabzabadi, H Pourmahmoud, MR Khodaie-Ardakani, ... Psychopharmacology 231, 533-542, 2014 | 45 | 2014 |
A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia M Noroozian, S Ghasemi, SMR Hosseini, A Modabbernia, ... Psychopharmacology 228, 595-602, 2013 | 44 | 2013 |
Intranasal desmopressin as an adjunct to risperidone for negative symptoms of schizophrenia: a randomized, double-blind, placebo-controlled, clinical trial SMR Hosseini, M Farokhnia, F Rezaei, A Gougol, H Yekehtaz, N Iranpour, ... European Neuropsychopharmacology 24 (6), 846-855, 2014 | 26 | 2014 |
Developing an ethical guideline for clinical teaching in Tehran University of Medical Sciences A Hashemi, H Yeketaz, F Asghari Journal of Medical Ethics and History of Medicine 8, 2015 | 6 | 2015 |
Low-dose human chorionic gonadotropin adjunct to an antagonist protocol in assisted reproductive technology: a randomized trial study M Aghahosseini, A Aleyasin, H Yekehtaz, L Kashani Acta Medica Iranica, 430-437, 2014 | 4 | 2014 |